Home Overview Press Room Blog Publications For Students about us

About Civil Society & Human Biotechnology

"Civil society" refers to institutional political actors outside of government and private enterprise, typically nonprofit advocacy organizations and foundations. The term "non-governmental organization," or NGO, is closely related.

Civil society organizations have come to play an important role in ensuring the accountability of governments, countering the power of corporations, and contributing to democratic governance.

For most of today’s important issues – war and peace, economic growth and equity, ecological sustainability, race and gender equality, and many others – there are dense networks of civil society institutions. For the issues surrounding human biotechnologies, a civil society infrastructure is just beginning to emerge. 

F.D.A. Targets Inaccurate Medical Tests, Citing Dangers and Costsby Robert PearThe New York TimesNovember 23rd, 2015Inaccurate, unreliable medical tests are prompting abortions, unnecessary surgeries, putting tens of thousands of people on unneeded drugs and raising medical costs.
Putting a Price on Human Eggs Makes No Senseby Debora SparFortuneNovember 21st, 2015No one wants to deal with the ugly reality that egg donation is not donation at all, but a high price paid for a piece of one’s body. We have identified this transaction and allowed it. Now we are only squabbling over the price.
F.D.A. Takes Issue With the Term ‘Non-G.M.O.’by Stephanie StromThe New York TimesNovember 20th, 2015In addition to balking at "organisms," the FDA argues an industry-serving definition of “genetic modification,” comparing thousands of years of breeding techniques to extremely modern synthetic biology tools.
New Rules Proposed to Address Privacy and Trust in the Precision Medicine Initiativeby Katayoun Chamany, Biopolitical Times guest contributorNovember 19th, 2015The US Precision Medicine Initiative's goal of a million sequenced genomes is helping to propel a revision to the Common Rule governing human subject research.
Move Over, Jony Ive — Biologists Are the Next Rock Star Designersby Liz StinsonWIREDNovember 18th, 2015A biotech startup that calls itself an "organism design foundry" and works with designers and artists is part of a US bioeconomy that already generates $350 billion annually.
End ‘stem cell tourism,’ experts urgeby Michael CookBioEdgeNovember 14th, 2015Stem cell scientists appear to have oversold their product. Now patients, tired of waiting for the cures they were promised, are seeking unproven stem cell-based treatments that are causing more harm than good.
[China] Couples in China making babies through assisted reproductionChina DailyNovember 14th, 2015Half of the 90 million Chinese women now allowed to have a second child are between the ages of 40 and 49, and many couples are turning to assisted reproduction clinics.
Why FBI and the Pentagon are afraid of gene drivesby Sharon BegleyStat NewsNovember 12th, 2015Officials from DARPA to the United Nations bioweapons office are concerned about the potential of “gene drives” to alter evolution in ways scientists can’t imagine.
23andMe Will Resume Giving Users Health Databy Andrew PollackThe New York TimesOctober 21st, 2015Two years after a forced hiatus from providing consumers with genetic health probabilities, the FDA has cleared 23andMe to provide carrier status and lactose intolerance tests.
Indigenous peoples must benefit from scienceby Dyna RochmyaningsihNature NewsOctober 20th, 2015The triple helix of science, the private sector, and government have driven the world’s economy since the Industrial Revolution, but to drive sustainable development, science must empower rural communities — not just serve industry and governments.
Displaying 1-10 of 528  
Next >> 
Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760